UCHealth is slicing the cost of a cancer drug after acknowledging it had been overcharging patients and insurance companies for years. The move, following a Coloradoan investigation into the health ...

DEERFIELD, Ill.--(BUSINESS WIRE)--TerSera Therapeutics LLC announced today the presentation of new real-world analyses on the treatment patterns of goserelin in women with breast cancer. The data were ...

A global drug manufacturer’s “disgusting” decision to discontinue a breast cancer and endometriosis treatment in Australia ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ZOLADEX 10.8 mg contains the active ingredient goserelin acetate.

Goserelin, a lutenizing hormone-releasing hormone agonist, reduces the long-term risk of disease recurrence and deaths in premenopausal women with early breast cancer who did not take tamoxifen, ...

WASHINGTON, May 30 (UPI) --The drug goserelin, sold by AstraZeneca under the brand name Zoladex, may help protect the ovaries of women with breast cancer. "It's not a panacea, but based on these data, ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. A drug that reduces the amount of estrogen in the body can help prevent ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ZOLADEX 3.6 mg contains the active ingredient goserelin acetate.

AstraZeneca is offloading yet another set of drug rights to streamline its portfolio and raise some cash. The U.K.-based drugmaker has agreed to hand over its cancer drug Zoladex in the U.S. and ...